|1.||Shirai, Tomoyuki: 2 articles (01/2005 - 06/2002)|
|2.||Suzuki, Shugo: 2 articles (01/2005 - 06/2002)|
|3.||Jeffrey, A M: 2 articles (08/2002 - 02/2002)|
|4.||Williams, G M: 2 articles (08/2002 - 02/2002)|
|5.||Iatropoulos, M J: 2 articles (08/2002 - 02/2002)|
|6.||Shirai, T: 2 articles (02/2002 - 03/2000)|
|7.||Gupta, Ramesh C: 1 article (02/2008)|
|8.||Neale, Jason R: 1 article (02/2008)|
|9.||Jeyabalan, Jeyaprakash: 1 article (02/2008)|
|10.||Ravoori, Srivani: 1 article (02/2008)|
|1.||Colonic Neoplasms (Colon Cancer)
02/01/2002 - "Protective effect of acetaminophen against colon cancer initiation effects of 3,2'-dimethyl-4-aminobiphenyl in rats."
08/01/1997 - "The widely used analgesic acetaminophen (APAP) was studied in rats for its ability to inhibit intestinal carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB), which was selected as the carcinogen because of its similarity to the heterocyclic amines formed during cooking and which are postulated to be involved in colon cancer in humans. "
08/01/2002 - "In these studies, we have investigated anticarcinogenicity of BHT against liver cancer in rats induced by either 2-acetylaminofluorene (AAF) or aflatoxin B1 (AFB1) and anticarcinogenicity of APAP against colon cancer induced in rats by 3,2'-dimethyl-4-aminobiphenyl (DMAB). "
|2.||Prostatic Neoplasms (Prostate Cancer)
03/01/1991 - "Trial to induce prostatic cancer in ACI/Seg rats treated with a combination of 3,2'-dimethyl-4-aminobiphenyl and ethinyl estradiol."
02/01/1990 - "Carcinomas of the rat prostate induced by a single injection of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, after sequential treatment with cyproterone acetate and testosterone propionate, were evaluated as potential animal models for prostatic cancer. "
|3.||Liver Neoplasms (Liver Cancer)
01/01/1996 - "Histopathological analysis of invasive bladder carcinomas induced by 3,2'-dimethyl-4-aminobiphenyl in hamsters."
05/01/1995 - "Ki-ras mutations with frequent normal allele loss versus absence of p53 mutations in rat prostate and seminal vesicle carcinomas induced with 3,2'-dimethyl-4-aminobiphenyl."
02/01/1990 - "In the groups treated with 3,2'-dimethyl-4-aminobiphenyl, which is slowly metabolized, these lesions were also found in groups that were pretreated with only CA. The carcinomas seemed to originate from the dorsolateral prostate and their average latency time was approximately 61 weeks. "
12/01/1986 - "Prostatic carcinomas were found in 18 of 21 rats (85.7%) after this treatment but in only 1 of 19 rats (5.2%) maintained on normal diet throughout the experiment but given 3,2'-dimethyl-4-aminobiphenyl at the same times as the diet given to test rats. "
01/01/1999 - "Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate."
05/01/1999 - "The aromatic amine carcinogen 3,2'-dimethyl-4-aminobiphenyl (DMABP) induces colon, prostate, and urinary bladder tumors in the rat, and a rapid and slow acetylator rat model has been characterized. "
02/13/1998 - "On the other hand, 3,2'-dimethyl-4-aminobiphenyl (DMAB) causes pancreatic acinar tumors. "
01/01/1996 - "Histopathological characteristics of urinary bladder tumors induced in Syrian golden hamsters by 3,2'-dimethyl-4-aminobiphenyl (DMAB) were analyzed. "
01/01/1993 - "Ultrasonic diagnosis of 3,2'-dimethyl-4-aminobiphenyl induced tumors in the urogenital organs of F344 rats."
05/01/1990 - "Tumorigenic response in the prostate of F344, ACI, Lewis, CD and Wistar rat strains to 3,2'-dimethyl-4-aminobiphenyl (DMAB) was examined in relation to development of other types of tumors. "
|1.||Ethinyl Estradiol (Estinyl)
|3.||Butylated Hydroxytoluene (BHT)
|4.||Aflatoxin B1 (Aflatoxin B)
|5.||2-Acetylaminofluorene (2 Acetylaminofluorene)
|10.||Butylated Hydroxyanisole (BHA)